Analysis of Parkinson's disease and subsequent cancer risk in Taiwan: A nationwide population-based cohort study

Neuroepidemiology

Volumn 37, Issue 2, 2011, Pages 114-119

  Sun, Li Min ^a   Liang, Ji An ^b,c   Chang, Shih Ni ^d,e   Sung, Fung Chang ^b,d   Muo, Chih Hsin ^b,d   Kao, Chia Hung ^b,c  

^a ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Cancer; Cohort study; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PARKINSON DISEASE; POPULATION RESEARCH; TAIWAN;

ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PARKINSON DISEASE; POPULATION SURVEILLANCE; RISK FACTORS; TAIWAN;

EID: 80053481083     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000331489     Document Type: Article

References (28)

1. de Lau LM, Breteler MM: Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525-535. (Pubitemid 44262284)
2. Muangpaisan W, Hori H, Brayne C: Systematic review of the prevalence and incidence of Parkinson's disease in Asia. J Epidemiol 2009;19:281-293.
3. Rajput AH, Birdi S: Epidemiology of Parkinson's disease. Parkinsonism Relat Disord 1997;3:175-186. (Pubitemid 28188827)
4. von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R: Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005;15:473-490. (Pubitemid 40949553)
5. Chen RC, Chang SF, Su CL, Chen TH, Yen MF, Wu HM, Chen ZY, Liou HH: Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan. Neurology 2001;57:1679-1686. (Pubitemid 33055489)
6. Doshay LJ: Problem situations in the treatment of paralysis agitans. J Am Med Assoc 1954;156:680-684.
7. Inzelberg R, Jankovic J: Are Parkinson disease patients protected from some but not all cancers? Neurology 2007;69:1542-1550. (Pubitemid 47537862)
8. Ferreira JJ, Neutel D, Mestre T, Coelho M, Rosa MM, Rascol O, Sampaio C: Skin cancer and Parkinson's disease. Mov Disord 2010;25:139-148.
9. Olsen JH, Friis S, Frederiksen K, McLaughlin JK, Mellemkjaer L, Moller H: Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer 2005;92:201-205. (Pubitemid 40188456)
10. Bajaj A, Driver JA, Schernhammer ES: Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control 2010;21:697-707.
11. Taipei Department of Health: Taiwan Cancer Registry. 2007. http://www.bhp.doh.gov.tw/BHPnet/Portal/StatisticsShow.aspx?No=201002050001.
12. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM: Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-1022. (Pubitemid 36628805)
13. Simon KC, Chen H, Schwarzschild M, Ascherio A: Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007;69:1688-1695. (Pubitemid 350287125)
14. Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J: Total cholesterol and the risk of Parkinson disease. Neurology 2008;70:1972-1979.
15. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J: Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2007;30:842-847. (Pubitemid 46562366)
16. Koller W, Vetere-Overfield B, Gray C, Alexander C, Chin T, Dolezal J, Hassanein R, Tanner C: Environmental risk factors in Parkinson's disease. Neurology 1990;40:1218-1221. (Pubitemid 20244978)
17. Schrag A, Ben-Shlomo Y, Quinn NP: Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ 2000;321:21-22. (Pubitemid 30417020)
18. Chen CC, Chen TF, Hwang YC, Wen YR, Chiu YH, Wu CY, Chen RC, Tai JJ, Chen TH, Liou HH: Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan. Neuroepidemiology 2009;33:350-357.
19. Office of the Surgeon General, Office on Smoking and Health: The health consequences of smoking: a report of the Surgeon General. Atlanta, Centers for Disease Control and Prevention, 2004.
20. Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T: A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev 2007;16:1260-1265. (Pubitemid 46984968)
21. Hernán MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ: A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002;52:276-284. (Pubitemid 35001493)
22. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P: Smoking and colorectal cancer: a meta-analysis. JAMA 2008;300:2765-2778.
23. Giovannucci E: An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725-731.
24. Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A: Family history of melanoma and Parkinson disease risk. Neurology 2009;73:1286-1291.
25. Smith DR, Sheu HM, Hsieh FS, Lee YL, Chang SJ, Guo YL: Prevalence of skin disease among nursing home patients in southern Taiwan. Int J Dermatol 2002;41:754-759. (Pubitemid 35422839)
26. Elbaz A, Moisan F: Update in the epidemiology of Parkinson's disease. Curr Opin Neurol 2008;21:454-460.
27. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL: Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol 2005;57:27-33. (Pubitemid 40053312)
28. Ragonese P, Salemi G, Morgante L, Aridon P, Epifanio A, Buffa D, Scoppa F, Savettieri G: A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease. Neuroepidemiology 2003;22:297-304. (Pubitemid 36993911)